Key Takeaways
- The ACD covers ABA under temporary demonstration authority rather than as a standard basic benefit, imposing enrollment requirements, mandatory assessments, and authorization cycles that civilian health plans do not require.
- ABA CPT codes remain on TRICARE’s No Government Pay List and providers cannot target activities of daily living; the demonstration expires December 31, 2028.
- DHA maintained as recently as August 2025 that ABA does not meet TRICARE’s evidence standard for proven medical care, a position the NASEM committee directly contradicted.
- A 310-page NASEM report released in September 2025 concluded ABA meets DoD’s own evidentiary standards and recommended the demonstration be discontinued in favor of a permanent basic benefit.
- The committee’s meta-analysis of 37 controlled trials found replicated positive ABA outcomes, supporting its conclusion that DHA’s contrary position is inconsistent with the evidence and with comparable government programs.
- As of April 2026, DHA has not acted on any of the NASEM recommendations; CASP is targeting the FY2027 NDAA after bringing 75 member organizations to Capitol Hill in March with TRICARE at the top of the agenda.
- Providers and families can contact their senators and representatives in support of the NASEM recommendations through CASP’s VoterVoice campaign at casproviders.org in about two minutes.
Military families with autistic children operate under a constraint their civilian counterparts do not: instability is structural. A duty station change every two to three years means new schools, new routines, and new providers, along with a new wait for all of it. For children with autism, who often depend on consistency as a clinical necessity, the military lifestyle compounds an already difficult situation. And for the past 11 years, the program governing how those children access one of the most widely prescribed autism therapies has asked them to do something that families under almost any comparable American health plan do not have to: clear an administrative obstacle course just to get started.
The Comprehensive Autism Care Demonstration, which the Defense Health Agency established in 2014, was designed as a temporary evaluation mechanism. It would cover applied behavior analysis for military families while the Pentagon decided whether the therapy met its standards for permanent coverage. That evaluation has been ongoing through two extensions and is now authorized to continue through December 31, 2028. In the meantime, the demonstration has accumulated a set of requirements that no comparable insurer imposes. Autism is the only TRICARE diagnosis requiring this kind of dual program enrollment to reach what would otherwise be a straightforward medical referral.
Last September, a committee convened by the National Academies of Sciences, Engineering, and Medicine delivered its verdict on all of this. The 310-page report, the product of a two-year congressionally mandated review, concluded that ABA meets the Department of Defense’s own criteria for reliable medical evidence, that the ACD’s policies lag behind current clinical science and best practices, and that the demonstration should be discontinued. As of April 2026, the Defense Health Agency is still reviewing the report.
The TRICARE Autism Care Demonstration: What Military Families Actually Face
The practical difference between ABA as a basic TRICARE benefit and ABA as a demonstration program is, in concrete terms, the difference between a medical referral and what the NASEM committee described as a process that military families “expressed stress and confusion” navigating.
Under the ACD, active-duty families must first enroll in the Exceptional Family Member Program, administered by their service branch, and separately in the Extended Care Health Option. Committee member Jennifer Penhale, an active-duty Air Force spouse and legislative and public policy committee chair of the Colorado Developmental Disabilities Council, stated during the committee’s September release webinar that autism is the only TRICARE diagnosis requiring both enrollments before a family can access medically recommended care. Once those steps are complete, families are assigned an Autism Services Navigator whose participation is mandatory. Four baseline outcome measure assessments must be administered before ABA services can begin. Authorization is granted in six-month intervals and must be renewed each cycle. A new referral from a diagnosing provider is required every two years.
The 2021 policy revision added the Parenting Stress Index Short Form and the Stress Index for Parents of Adolescents as mandatory instruments, administered every six months. Families told the committee these assessments felt invasive, clinically irrelevant, and offered nothing useful to their children’s treatment. One parent described a two-year waitlist just for an initial diagnostic evaluation in El Paso, Texas, and noted that for families who change duty stations frequently, that wait effectively means never being seen at all.
The clinical restrictions compound the access barriers. Under the ACD, providers are prohibited from targeting activities of daily living: dressing, hygiene, self-care. The AMA’s CPT codes for ABA explicitly include those goals, and so does standard clinical practice across the country. ABA CPT codes also remain on TRICARE’s No Government Pay List, a category reserved for services not authorized as standard covered medical care. The committee also found that the ACD’s approach to treating dose response as a fixed variable reflects a misunderstanding of how individualized ABA therapy hours are properly determined; current standards call for the clinical team to set the appropriate amount based on each client’s individual needs.
The Department of Defense began covering ABA for military beneficiaries in 2001, well before most states required commercial insurers to follow suit; the first state mandates came in 2007, and the last states adopted coverage requirements in 2019. The ACD’s policies, the committee found, did not keep pace with the field the military had helped build.
What the NASEM Report Found About TRICARE ABA Coverage
The committee was a 16-member panel chaired by George Rutherford, MD, a professor of epidemiology at the University of California San Francisco, with members drawn from behavior analysis, child development, biostatistics, public health, and the lived experience of autistic individuals and military families. Over two years, they reviewed the scientific literature and the evidence base for ABA, commissioned an independent meta-analysis, and analyzed de-identified TRICARE claims data covering 109,073 children ages 1 to 18 who were TRICARE-eligible between 2018 and 2023. Of those, roughly one-third had at least one ABA services claim. In FY2023, according to DHA’s own annual report to Congress, 16,747 beneficiaries were enrolled in the ACD at a total cost of $435 million and an average per-participant cost of $25,948.
That same August 2025 annual report reiterated a claim DHA has made for years: that ABA services do not meet TRICARE’s hierarchy of reliable evidence standard for proven medical care. The NASEM committee, working from the DoD’s own evidentiary criteria, arrived at the opposite conclusion. Their commissioned meta-analysis identified 37 controlled trials of comprehensive ABA programs, including four randomized controlled trials, and found replicated positive outcomes in IQ and adaptive behavior for autistic children between ages two and nine. The committee concluded that DHA’s position was not supported by the evidence, that it applied a higher standard to ABA than to other therapies covered as basic TRICARE benefits, and that ABA meets the Department’s own criteria. The report found that DHA’s position was out of step with developments in the ABA field, inconsistent with positions held by major medical and healthcare organizations, and contrary to how comparable government programs, including Medicaid and the Federal Employees Health Benefits Program, treat the therapy.
The five recommendations that follow are specific. DHA should discontinue the demonstration and authorize ABA as a standard TRICARE benefit, including moving ABA CPT codes off the No Government Pay List and establishing reimbursement rates consistent with other covered services. It should immediately halt the required periodic administration of the PDDBI, Vineland-3, SRS, and both parenting stress indices, which the committee found had no coherent evaluation plan to justify their use and placed growing burdens on families and providers with limited clinical benefit. It should reduce administrative barriers: make the Navigator optional, give providers flexibility to choose assessment tools, and make caregiver training optional. It should expand coverage to include activities of daily living, all ABA CPT codes, and delivery in school and community settings. And it should create an independent advisory council to guide the transition. In their concluding remarks, the committee wrote that the military had once led the country on autism care coverage, and that the demonstration it built to study that coverage had “not kept pace with scientific and medical developments related to autism and ABA.” The full report is available at nationalacademies.org.
The Defense Health Agency’s Response: Still Under Review
When the report was released, DHA told Military Times it was “carefully reviewing” the findings and would continue the ACD in the interim. Six months later, the program runs as it did before: same assessments, same enrollment requirements, same setting restrictions. The FY2027 National Defense Authorization Act cycle is the advocacy community’s primary legislative target, and the groundwork is already being laid.
Getting directive language into the NDAA requires congressional offices on the Armed Services committees to treat the issue as a priority and protect it through a process in which hundreds of provisions compete for space. CASP VP of Government Affairs Mariel Fernandez was direct about the timeline when the report was released. “It’s not going to happen overnight,” she said. “But this allows us to be able to point congressional offices to a key set of findings that then can be incorporated into the next National Defense Authorization Act as soon as possible, which will then direct the DHA to make these changes.” CASP’s 2026 DC Fly-In brought 75 member organizations to Capitol Hill in March with TRICARE at the top of the agenda. The organization maintains a year-round bipartisan lobbying presence in Washington and has been building relationships with Armed Services committee staff for years in preparation for exactly this kind of ask.
The political environment complicates but does not fundamentally alter the calculus. Federal attention to autism policy has rarely been higher, though not always in directions the provider community welcomes. Autism remains a genuinely bipartisan issue at the congressional level. The NASEM review was authorized with bipartisan support, the Congressional Autism Caucus draws members from both parties, and the advocacy coalition pressing for action includes both provider-focused organizations and military family organizations such as MOAA, which backed the FY2022 NDAA language that commissioned the review.
How ABA Providers and Military Families Can Move TRICARE ABA Coverage Forward
Dr. Rebecca Thompson, BCBA-D, Senior Director for Advocacy at LEARN Behavioral, has been among the clinicians publicly amplifying the NASEM findings and pointing colleagues toward action. Her message is straightforward: the committee has done the analytical work, the 2028 expiration is approaching, and the window for the FY2027 NDAA is open now.
CASP has made that argument actionable through a VoterVoice campaign at casproviders.org that allows providers, families, and advocates to contact their senators and House representatives with personalizable messaging in support of the NASEM recommendations. The campaign takes two minutes. CASP previously used the same VoterVoice infrastructure to generate constituent pressure on the credentialing and claims-processing disruptions that accompanied the T-5 contract transition to Humana Military and TriWest Healthcare Alliance in January 2025.
State-by-state campaigns require the same investment in each of 50 Medicaid programs. TRICARE is federal. A single statutory provision in the NDAA changes coverage for military families at every duty station simultaneously, delivering in one step what state campaigns would require 50 times over. For a provider workforce already stretched thin, that efficiency is not theoretical.
The NASEM committee provided the evidentiary foundation. The military was an early leader on ABA coverage. The program it built to study that coverage accumulated, over 11 years, policies that families describe as confusing, burdensome, and clinically counterproductive. Whether the Pentagon and Congress act on the committee’s findings before the demonstration expires is, at this point, a question of policy and timing, not of science.
Frequently Asked Questions
Does TRICARE cover ABA therapy for autism?
Yes, but under a demonstration program rather than as a standard basic benefit, which creates meaningful practical differences. The TRICARE Comprehensive Autism Care Demonstration has covered ABA services for eligible beneficiaries since July 25, 2014, and is authorized through December 31, 2028. Active-duty family members must first enroll in the Exceptional Family Member Program and the Extended Care Health Option before they can access ABA, requirements that exist only for autism among TRICARE diagnoses. After enrollment, families are assigned a mandatory Autism Services Navigator, must complete four baseline assessments before services begin, and go through six-month reauthorization cycles. ABA CPT codes remain on TRICARE’s No Government Pay List, and providers are prohibited from targeting activities of daily living as treatment goals. In FY2023, DHA reported 16,747 beneficiaries enrolled in the program at a total cost of $435 million. In September 2025, the National Academies of Sciences, Engineering, and Medicine concluded that ABA meets DoD’s own evidentiary standards and recommended authorizing it as a standard TRICARE basic benefit.
How does TRICARE ABA coverage compare to civilian insurance?
Military families accessing ABA through the TRICARE Autism Care Demonstration face administrative requirements that civilian families covered by commercial or Medicaid plans generally do not. All 50 states have required commercial insurers to cover ABA as of 2019, and Medicaid programs cover ABA under the Early and Periodic Screening, Diagnostic, and Treatment mandate for beneficiaries under 21. Neither commercial plans nor Medicaid require the dual program enrollment (EFMP and ECHO) that the ACD imposes on active-duty families. The mandatory parenting stress indices required every six months under the ACD have no equivalent in standard commercial coverage. Restrictions on targeting activities of daily living and on delivering services in school and community settings also set the ACD apart from general practice. The NASEM committee found that “military families likely encounter more administrative barriers to accessing ABA services than civilian families” and that the ACD’s policies are inconsistent with generally accepted standards of care. The committee also found that DHA applies a higher evidentiary standard to ABA than it does to speech, occupational, and physical therapy, all of which are covered as standard TRICARE basic benefits.
What did the 2025 National Academies report on TRICARE ABA coverage recommend?
The report, titled “The Comprehensive Autism Care Demonstration: Solutions for Military Families” and released September 9, 2025, contains five recommendations directed at the Defense Health Agency. Recommendation 1: DHA should discontinue the ACD and authorize ABA as a basic TRICARE benefit, moving ABA CPT codes off the No Government Pay List and establishing consistent reimbursement rates. Recommendation 2: DHA should immediately halt the required periodic administration of four specific assessment instruments, the PDDBI, Vineland-3, and SRS, along with the Parenting Stress Index Short Form and the Stress Index for Parents of Adolescents. The committee found these instruments had no well-designed evaluation plan justifying their use and placed growing burdens on families and providers. Recommendation 3: DHA should reduce administrative barriers, making the Autism Services Navigator optional, giving providers flexibility to choose clinically appropriate assessments, and making caregiver training flexible rather than mandatory. Recommendation 4: DHA should expand coverage to include activities of daily living and maladaptive behaviors, approve all ABA CPT codes, permit higher staff-to-client ratios and crisis intervention procedures where clinically appropriate, and remove setting restrictions to allow services in schools and community environments. Recommendation 5: DHA should establish an independent advisory council to guide the transition and provide ongoing input on implementation and quality of care.
Has the Defense Health Agency acted on the NASEM TRICARE ABA coverage report?
As of April 2026, the Defense Health Agency has not announced any structural changes to the Autism Care Demonstration or a timeline for acting on the NASEM recommendations. In a statement provided to Military Times when the report was released in September 2025, DHA said it was “carefully reviewing” the findings and would continue the ACD pending that review. DHA’s most recent annual report to Congress, dated August 19, 2025, still stated that ABA does not meet TRICARE’s hierarchy of reliable evidence standard for proven medical care, a position the NASEM committee directly contradicted based on a commissioned meta-analysis of 37 controlled trials. The ACD continues to operate in the same form it has had since DHA’s 2021 policy revision. Advocacy organizations including CASP are focused on the FY2027 National Defense Authorization Act cycle as the most direct legislative vehicle for directing DHA to act, with the Armed Services committees in both the House and Senate as the primary congressional targets. The growing scrutiny of ABA billing and documentation across Medicaid and other federal programs makes establishing a stable, well-defined TRICARE coverage framework more important, not less.
How can ABA providers take action to support permanent TRICARE ABA coverage?
CASP has organized a VoterVoice campaign that allows providers, families, and advocates to contact their U.S. senators and House representatives with personalizable messaging in support of the NASEM recommendations. The campaign is accessible at casproviders.org and takes approximately two minutes to complete. Providers who currently serve or have served TRICARE-enrolled children, or who have direct experience navigating the ACD’s administrative requirements, are well positioned to personalize the messaging with specific clinical examples. Congressional offices on the House and Senate Armed Services committees are the most relevant targets, as the National Defense Authorization Act is the primary legislative vehicle for directing the Defense Health Agency to act. Beyond the campaign, providers who contribute to the accountability standards taking shape across the ABA field, through defensible documentation, clinical quality measurement, and individualized treatment planning, contribute to the broader evidentiary foundation that makes the NASEM recommendations harder to resist.
What happens to TRICARE ABA coverage when the Autism Care Demonstration expires in 2028?
The ACD’s December 31, 2028 expiration creates structural uncertainty for military families whose children depend on ABA therapy. The demonstration has been extended twice since its 2014 launch, so another extension is possible, but it would perpetuate the same administrative requirements that the NASEM committee recommended eliminating. If the demonstration ends without a permanent coverage mechanism in place, families could face disruption to ongoing care with no immediate alternative pathway. Transitioning to basic TRICARE benefit status would eliminate the expiration risk and provide coverage portability that military families need across frequent relocations. The NASEM committee specifically cited the 2028 deadline as a reason to pursue a clean transition rather than another extension. Committee member Dr. Eric Flake, a retired Air Force colonel and developmental-behavioral pediatrician, noted at the committee’s release webinar that roughly 1,000 military children receive an autism diagnosis each month. For those families, the difference between a demonstration program with a four-year horizon and a permanent benefit is not administrative; it is a question of whether they can plan for continuous care across their children’s developmental years.
